Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00695565 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy
A Phase 2 study of Painful Diabetic Neuropathy, sponsored by Arcion Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 16
- Study locations
NCT00695565 is a Phase 2 study of Painful Diabetic Neuropathy that has completed, run by Arcion Therapeutics. The registered enrollment target is 180 participants, above the 96-participant average among 5 other Painful Diabetic Neuropathy trials with a reported enrollment target (88% higher). The trial reports 16 study locations across 14 states.
The verdict
NCT00695565, a Phase 2 study of Painful Diabetic Neuropathy, has completed, sponsored by Arcion Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.
Conditions Studied
Interventions
- DRUG Placebo Gel
- DRUG Clonidine Topical Gel (ARC-4558)
Study Locations (16)
California
- Northern California Research - Sacramento
- Neurological Research Institute - Santa Monica
Texas
- The Nerve and Muscle Center of Texas - Houston
- Diabetes and Glandular Disease Center - San Antonio
Alabama
- University of Alabama at Birmingham, School of Medicine - Birmingham
Florida
- Metabolic Research Institute - West Palm Beach
Kentucky
- Pain Treatment Center of the Bluegrass - Lexington
Louisiana
- Tulane University Health Sciences Center - New Orleans
Massachusetts
- University of Massachuetts Medical School, Division of Diabetes- Clinical Research Office - Worcester
Nebraska
- The Creighton Diabetes Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00695565
The ClinicalTrials.gov registry entry for NCT00695565 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 5 other Painful Diabetic Neuropathy trials with a reported enrollment target (88% higher). The listed sponsor is Arcion Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Painful Diabetic Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo Gel is the first listed.
NCT00695565 reports 16 study locations spanning 14 distinct geographic areas - top geographies include California, Texas, Alabama.
Frequently Asked Questions
What is clinical trial NCT00695565 about?
NCT00695565 is a clinical study titled "Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy". The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.
What is the current status of trial NCT00695565?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2008-05. Estimated completion is 2010-02.
What conditions does trial NCT00695565 study?
This clinical trial studies the following conditions: Painful Diabetic Neuropathy.
What interventions are being tested in trial NCT00695565?
The interventions under investigation include: Placebo Gel (DRUG), Clonidine Topical Gel (ARC-4558) (DRUG).
Who is sponsoring clinical trial NCT00695565?
This trial is sponsored by Arcion Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00695565 being conducted?
This trial has 16 study locations across Alabama, California, Florida, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Painful Diabetic Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
RECRUITING · Phase 2
-
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
COMPLETED · Phase 2
-
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
RECRUITING · NA
-
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
RECRUITING
-
Pain and Neurological Function Improvements With 10 kHz Spinal Cord Stimulation Treatment of Painful Diabetic Neuropathy
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.